Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population

被引：0
|
作者：
Lin, Derek [1 ]
Nguyen, Nghia H. [2 ]
Hoang, Joseph [3 ]
Vu, Vinh D. [3 ]
Trinh, Huy N. [4 ]
Li, Jiayi [5 ]
Zhang, Jian Q. [6 ]
Nguyen, Huy A. [4 ]
Khanh Nguyen [4 ]
Nguyen, Mindie H. [3 ]
机构：
[1] Stanford Univ Med Ctr, Palo Alto, CA USA
[2] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[3] Stanford Univ Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[4] San Jose Gastroenterol, San Jose, CA USA
[5] Palo Alto Med Fdn, Palo Alto, CA USA
[6] Chinese Hosp, San Francisco, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1641
引用
收藏
页码：988A / 988A
页数：1
相关论文
共 50 条
  • [31] Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    van Boemmel, Florian
    Buti, Maria
    Sypsa, Vana
    Goulis, John
    Calleja, Jose L.
    Chi, Heng
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Gatselis, Nikolaos
    Keskin, Onur
    Lehretz, Maria
    Savvidou, Savvoula
    de la Revilla, Juan
    Hansen, Bettina E.
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Berg, Thomas
    Lampertico, Pietro
    HEPATOLOGY, 2016, 64 : 35A - 36A
  • [32] Impact of Antiviral Therapy on Risk Prediction Models for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Chon, Hye Yeon
    Lim, Tae Seop
    Jeon, MiYoung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seunq Up
    HEPATOLOGY, 2018, 68 : 1231A - 1232A
  • [33] Incidence of Hepatocellular Carcinoma (HCC) in non-cirrhotic chronic hepatitis B (CHB) patients with low ALT levels in a multicenter US Cohort
    Hoang, Joseph K.
    Nguyen, Nghia H.
    Lin, Derek
    Vu, Vinh D.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Huy A.
    Nguyen, Khanh
    Nguyen, Mindie H.
    HEPATOLOGY, 2014, 60 : 1088A - 1088A
  • [34] Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Chon, Hye Yeon
    Lee, Jae Seung
    Lee, Hye Won
    Chun, Ho Soo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 406 - 416
  • [35] Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
    Jang, Heejoon
    Lee, Yun Bin
    Moon, Hyemi
    Chung, Jong-Won
    Nam, Joon Yeul
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Lee, Juneyoung
    Yoon, Jung-Hwan
    HEPATOLOGY, 2022, 76 (02) : 492 - 501
  • [36] A novel and simple real world predictive risk score (RWS-HCC) for the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) infection
    Poh, Zhongxian
    Shen, Liang
    Goh, Boon Bee George
    Chang, Jason
    Tan, Chee-Kiat
    HEPATOLOGY, 2013, 58 : 1227A - 1227A
  • [37] Incidence and Risk Factors in the Development of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients with Chronic Hepatitis B (CHB): Results of a Multicenter US Cohort Study
    Sonu, Irene S.
    Nguyen, Long H.
    Chen, Christy
    Kin, Kevin C.
    Ha, Nghiem B.
    Trinh, Huy N.
    Ahmed, Aijaz
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Mindie H.
    HEPATOLOGY, 2012, 56 : 478A - 479A
  • [38] Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis
    Jeng, Wen-Juei
    Liaw, Yun-Fan
    SEMINARS IN LIVER DISEASE, 2021, 41 (03) : 349 - 357
  • [39] Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Okada, Masako
    Enomoto, Masaru
    Kawada, Norifumi
    Nguyen, Mindie H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (12) : 1095 - 1104
  • [40] HEPATOCELLULAR CARCINOMA (HCC) RISK ESTIMATION BASED ON CHRONIC HEPATITIS B (CHB) VIRAL LOAD LEVELS IN BRAZILIAN PATIENTS
    Cheinquer, H.
    Nita, M.
    Litalien, G.
    Araujo, E.
    Mantilla, P.
    Cure-Bolt, N.
    Bensenor, I
    Lotufo, P.
    Gaburo, J. N.
    VALUE IN HEALTH, 2009, 12 (07) : A515 - A515
12345